Matrix metalloproteinases and abdominal aortic aneurysms: A potential therapeutic target

Journal of Clinical Pharmacology

Volumn 38, Issue 12, 1998, Pages 1077-1088

  Sinha, Sanjai ^a   Frishman, William H ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; COLLAGENASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; GELATINASE A; GELATINASE B; ILOMASTAT; INDOMETACIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; ENZYME INHIBITION; HUMAN; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

AORTIC ANEURYSM, ABDOMINAL; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032415706     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Reilly JM, Tilson MD: Incidence and etiology of abdominal aortic aneurysms. Surg Clin North Am 1989;69:705-711.
2. Ernst CB: Abdominal aortic aneurysm. N Engl J Med 1993;328: 1167-1172.
3. Melton L, Bickerstaff L, Hollier L, VanPeenen HJ, Lie JT, Pairolero PC, et al: Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 1984;120:379-386.
4. Milewicz DM, Michael K, Fisher N, Coselli JS, Maikello T, Biddinger A: Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 1996;94:2708-2711.
5. Kuivaniemi H, Tromp G, Prockop DJ: Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J 1991;5:2052-2060.
6. Dobrin PB: Pathophysiology and pathogenesis of aortic aneurysms. Surg Clin North Am 1989;69:687-703.
7. Campa JS, Greenhalgh RM, Powell JT: Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 1987;65:13-21.
8. Busuttil RW, Rinderbriecht H, Fleisher A, Carmack C: Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res 1982;32:214-217.
9. Thompson RW, Parks WC: Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:157-174.
10. Celentano D, Frishman W: Matrix metalloproteinases and coronary artery disease: a novel therapeutic target. J Clin Pharmacol 1997;37:991-1000.
11. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
12. Dollery CM, McEwan JR, Henney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-868.
13. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-1151.
14. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH: Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990;137:1199-1213.
15. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH: In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 1995;15: 1139-1144.
16. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al: Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. J Clin Invest 1995;96: 318-326.
17. Patel MI, Melrose J, Ghosh P, Appleberg M: Increased synthesis of matrix metallo-proteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 1996;24:82-92.
18. Evans CH, Georgescu BS, Lin C, Mendelow D, Steed D, Webster MW: Inducible synthesis of collagenase and other natural metalloproteinases by cells of aortic origin. J Surg Res 1991;51: 399-404.
19. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD: Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 1994;30:265-276.
20. Nikarri ST, Hoyhtya M, Isola J, Nikarri T: Macrophages contain 92-kd gelatinase at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996;149:1427-1433.
21. Vine N, Powell JT: Metalloproteinases in degenerative aortic disease. Clin Sci 1991;81:233-239.
22. Knox JB, Sukhova GK, Whittemore AD, Libby P: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-212.
23. Murphy G, Cockett MI, Ward RV, Doherty AJP: Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J 1991;277:277-279.
24. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metallo-proteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
25. McMillan WD, Patterson BK, Keen RR, Pearce WH: In situ localization and quantification of 72-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 1995;22:295-305.
26. Adiseshiah M, Macsweeney STR, Henney AM: Abdominal aortic aneurysm. Lancet 1993;341:215-220.
27. Kuivaniemi H, Watton SJ, Price SJ, Zhu Y, Gatalica Z, Tromp G: Candidate genes for abdominal aortic aneurysm. Ann N Y Acad Sci 1996;800:186-197.
28. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi R, Nagase H, Tilson MD: Identification of matrix metalloproteinase 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1994;14:1315-1320.
29. Ogata Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayawaka T: Matrix metalloproteinase 3 activates the precursor of human matrix metalloproteinase 9. J Biol Chem 1992;267:3581-3584.
30. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H: Mechanisms of activation of tissue procollagenase by matix metalloproteinase 3. Biochem J 1990;29:10261-10270.
31. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrisey E, Unemori EN, Lark MW, et al: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-189.
32. Schontal A, Herrlich P, Rahmsdorf HJ, Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988;54:325-334.
33. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995;748:501-507.
34. Malik N, Greenfield BW, Wahl AF, Kiener PA: Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996;156:3952-3960.
35. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC: Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases -1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 1996;315:335-342.
36. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC: Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:5:2327-2333.
37. Werb Z: Matrix metalloproteinases. In, Proceedings of the International Business Cummunications Conference on Matrix Metalloproteinases in Tissue Remodeling, San Fransisco, California, May 5-7, 1997. Southborough, MA: International Business Communications, 1997.
38. Birkedal-Hansen H, Engler J: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
39. Kishnani N, Yang T, Masiarz F, Hawkes S: Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol 1995;14:479-488.
40. Leco KJ, Khokka R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinase-3 is an extracellular matrix associated protein with a distinctive pattern of expression in mouse cells. J Biol Chem 1994;269:9352-9360.
41. Ward RV, Atkinson SJ, Slocombe AJ, Docherty AJ, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem Biophys Acta 1991;1079:242-246.
42. Yang TT, Hawkes SP: Role of the 21 kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 1992;89:10676-10680.
43. Brophy CM, Marks WH, Reilly JM, Tilson MD: Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res 1991;50:653-657.
44. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement in the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb Vasc Biol 1991; 11:1667-1677.
45. Tyagi S, Meyer L, Kumar S, Schmaltz RA, Reddy H, Voelker DJ: Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can J Cardiol 1996;12:4:353-362.
46. Chesler L, Golde DW, Barsch N, Johnson MD: Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinase-1. Blood 1995;86: 4506-4515.
47. Brophy CM, Reilly JM, Walker GJ, Tilson MD: The role of inflammation in nonspecific aneurysm disease. Ann Vasc Surg 1991;5:229-233.
48. Anidjar S, Dobrin PB, Eichorst M, Graham GP, Chejfec G: Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg 1992;16:139-147.
49. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG: Neutral proteinases of human mononuclear phagocytes. J Immunol 1991;146:1286-1293.
50. Kumar R, Dong Z, Fidler IJ: Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J Immunol 1996;157:5104-5111.
51. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, Tilson MD: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-820.
52. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG: Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol 1995;154:12: 6484-6491.
53. Lacraz S, Isler P, Vey E, Welgus HG, Dayer JM: Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 1994;269: 22027-22033.
54. Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, Yao JS, Pearce WH: Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells. J Vasc Surg 1994;20:774-784.
55. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P: Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signalling in plaque rupture? Circ Res 1997;81:3:448-454.
56. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997;150:993-1007.
57. Szekanecz Z, Shah MR, Pearce WH, Koch AE: Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol 1994;98:337-343.
58. Holmes DR, Liao S, Parks WC, Thompson RW: Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg 1995;21:761-772.
59. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW: Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996;23:336-346.
60. Holmes DR, Petrinec D, Wester W, Thompson RW, Reilly JM: Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 1996;63:305-309.
61. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 1996; 16:28-33.
62. Bendeck MP, Irvin C, Reidy MA: Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 1996;78: 38-43.
63. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ: Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1994;1(Suppl 1):S10-S13.
64. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, et al: Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human AAA. Am J Pathol 1993;142:1423-1431.
65. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, Egido J: ACE-inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997;95:1532-1541.
66. Holmes DR, Wester W, Thompson RW, Reilly JM: Prostaglandin E2 synthesis and cycoloxygenase expression in abdominal aortic aneurysms. J Vasc Surg 1997;25:810-815.
67. Fernandez OA, Meyer BJ, Mailhac A, Falk E, Badimon L, Fallon JT, et al: A new approach for local intravascular drug delivery: iontophoretic balloon. Circulation 1994;89:1518-1522.
68. Meyer BJ, Fernandez OA, Mailhac A, Falk E, Badimon L, Michael AD, et al: Local delivery of r-hirudin by a double balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994;90:2474-2480.